Live Quote · NASDAQPMCBHealthcare· Biotechnology

PharmaCyte Biotech, Inc.

$3.98▼ 12.83%($-0.58)
MKT CAP $2.25MNEXT EARNINGS Dec 16, 2026
50%
Bullish
TickerSpark Score
44/100
▌ Weak
87
Valuation
20
Profitability
15
Growth
68
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PMCB research report →

Analyst RatingHold
0 Buy1 Hold0 Sell

Price Chart

-66.75% · this period
$23.18$13.58$3.98Nov 20May 26Nov 20
52-Week Range0% of range
Low
$3.98
Current
$3.98
High
$28.69